You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤醫療(01515.HK):擬關停淮陰醫院業務
格隆匯 05-10 16:37

格隆匯5月10日丨華潤醫療(01515.HK)公佈,有關集團計提淮安市淮陰醫院有限公司("淮陰醫院")相關減值的公吿如公司2022年及2023年年度報吿及該公吿所述之醫護人員逐漸流失等歷史遺留問題影響以及區域醫療保障資源、同行業競爭情況等外部環境變化,淮陰醫院經營情況持續下滑,陷入虧損。儘管集團已積極實施人才招攬、業務轉型、組織重塑和降本增效等多項舉措,但仍未能扭轉淮陰醫院的經營狀況。經對當地醫療市場深入研究,結合淮陰醫院目前情況進一步研判,公司管理層認為淮陰醫院目前缺乏業務發展機會且經營虧損將持續較長時間,相較持續經營,淮陰醫院停止經營系現階段得以最大程度降低公司損失、防控項目風險的選擇,因此公司擬於公吿發布後向行業監管部門就淮陰醫院作停止經營的申請,並待獲得批准之後對淮陰醫院之業務實施關停安排。

根據公司基於現有資料的評估,淮陰醫院業務關停預計會產生相關的一次性費用;此外,預計2024年因應資產折舊或攤銷將形成非現金性成本。上述事項將會對集團2024年經營業績帶來一定程度影響,但考慮到淮陰醫院預計較長期間無法通過經營實現扭虧,公司認為長期來看淮陰醫院業務關停有利於公司的未來經營業績。同時,從淮陰醫院的收入規模、診療人次、專家資源等維度綜合評估,預計淮陰醫院業務關停對集團業務發展的影響較小。

目前公司正研究淮陰醫院業務關停後之人員、資產的處理方案,包括考慮出售所持淮陰醫院相應股權或淮陰醫院資產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account